• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exelixis Inc (NQ: EXEL )

34.12 +0.92 (+2.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exelixis Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
3 Magnificent Stocks Under $100 to Buy in November
Today 6:41 EST
The price could be right for these stocks. 
Via The Motley Fool
Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Today 3:30 EST
The top 10 performers last week were Reddit, Paycom, Mobileye, Exelixis, Garmin, Roblox, Twilio, Snap, Waters, and Atlassian. Many analysts raised price forecasts. 
Via Benzinga
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
October 30, 2024
Via Benzinga
Exelixis (EXEL) Q3 2024 Earnings Call Transcript
October 30, 2024
EXEL earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Preview: Exelixis
October 28, 2024
Via Benzinga
1 No-Brainer Stock to Buy With $40
October 23, 2024
The midcap biotech just became an even better buy. 
Via The Motley Fool
Analyst Ratings For Exelixis
October 21, 2024
Via Benzinga
Navigating 16 Analyst Ratings For Exelixis
October 21, 2024
Via Benzinga
Exelixis Announces Third Quarter 2024 Financial Results and Provides Corporate Update
October 29, 2024
From Exelixis, Inc.
Via Business Wire
Biotech Momentum Trades For The Q4 Rally
October 29, 2024
The biotech sector made an interim peak in late February followed by an active summer in very choppy trading. 
Via Talk Markets
Momentum Has Narrowed Again, Significantly
October 28, 2024
It is more of a stock pickers market than usual as momentum factors are currently exaggerated. 
Via Talk Markets
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
October 18, 2024
In a market where value is scarce, EXELIXIS INC (NASDAQ:EXEL) offers a refreshing opportunity with its solid fundamentals. 
Via Chartmill
Exelixis to Release Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
October 15, 2024
From Exelixis, Inc.
Via Business Wire
Key Takeaways From Exelixis Analyst Ratings
October 04, 2024
Via Benzinga
A Closer Look at 5 Analyst Recommendations For Exelixis
September 18, 2024
Via Benzinga
Exelixis Announces Update on Second Patent Litigation Trial with MSN Laboratories
October 15, 2024
From Exelixis, Inc.
Via Business Wire
Exelixis and Merck Sign Clinical Development Collaboration to Evaluate Investigational Zanzalintinib in Combination with KEYTRUDA® (pembrolizumab) in Head and Neck Cancer and in Combination with WELIREG® (belzutifan) in Renal Cell Carcinoma
October 14, 2024
From Exelixis, Inc.
Via Business Wire
Blue Skies, New Highs Remain Disciplined And Do Not Chase Extended Ideas
October 13, 2024
It is Fall clean up time. Sell lagging and sagging companies. 
Via Talk Markets
NASDAQ:EXEL, an undervalued stock with good fundamentals.
August 15, 2024
Don't overlook EXELIXIS INC (NASDAQ:EXEL)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
Expert Outlook: Exelixis Through The Eyes Of 5 Analysts
August 08, 2024
Via Benzinga
NASDAQ:EXEL appears to be flying under the radar despite its strong fundamentals.
September 27, 2024
For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals. 
Via Chartmill
2 Growth Stocks to Buy With Less Than $100
September 26, 2024
No need to break the bank to get in on these likely long-term winners. 
Via The Motley Fool
Exelixis Announces Final Results from Phase 3 Pivotal CABINET Study Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2024 and Published in New England Journal of Medicine
September 16, 2024
From Exelixis, Inc.
Via Business Wire
Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Castration-Resistant Prostate Cancer at ESMO 2024
September 15, 2024
From Exelixis, Inc.
Via Business Wire
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
September 06, 2024
EXELIXIS INC (NASDAQ:EXEL): good value for what you're paying. 
Via Chartmill
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in September
August 28, 2024
From Exelixis, Inc.
Via Business Wire
3 Stocks to Buy for a Soft Landing, If There Is One
August 15, 2024
Recent economic data is reigniting talk about a soft landing for the economy; here are three stocks to consider if a soft landing materializes 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
August 09, 2024
After Monday's panicked global sell-off, markets have calmed down. 
Via Investor's Business Daily
Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results
August 07, 2024
Exelixis reports strong Q2 earnings with adjusted EPS of $0.84, surpassing estimates. The CONTACT-02 trial for mCRPC showed significant PFS benefit but OS did not achieve statistical significance.... 
Via Benzinga
Exposures Product Safety
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
August 07, 2024
Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap